[1]
Makwana, S.P. and Solanki, M.N. 2019. Comparative analysis of safety and efficacy of cefotaxime/sulbactam verses piperacillin/tazobactam combinations in the treatment of complicated urinary tract infections. International Journal of Basic & Clinical Pharmacology. 8, 3 (Feb. 2019), 512–519. DOI:https://doi.org/10.18203/2319-2003.ijbcp20190657.